Mesothelioma Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Study of CAR.70-engineered IL15-transduced Cord Blood-derived NK Cells in Conjunction With Lymphodepleting Chemotherapy for the Management of Advanced Renal Cell Carcinoma, Mesothelioma and Osteosarcoma
Conditions: Advanced Renal Cell Carcinoma; Advanced Mesothelioma; Advanced Osteosarcoma Interventions: Drug: CAR.70/IL15-transduced CB-derived NK cells; Drug: Fludarabine phosphate; Drug: Cyclophosphamide Sponsor: M.D. Anderson Cancer Center Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 30, 2023 Category: Research Source Type: clinical trials

AIO-BNHO Comprehensive Clinico-genomics Database Network - AIO-BNHO CONNECT
Condition: Patients With Advanced Solid Tumor (Excluding NSCLC, SCLC, and Mesothelioma) With Results From a Multi-gene Next-generation Sequencing (NGS) Panel (>30 Genes) Interventions: Other: Minimal documentation; Other: Extended documentation Sponsor: AIO-Studien-gGmbH Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 27, 2023 Category: Research Source Type: clinical trials